CAI
Caris Life Sciences, Inc. · Healthcare · Market cap $10.2B
Insiders sold $26.2M net in the last 90 days ·3 sellers, 1 buyer· latest Form 4 filed Sep 23, 2026
Insider Buying
$1.6M
reported purchases (SEC code P)
Insider Selling
$28.9M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Sep 23, 2026
Denton John Russel
Caris Life Sciences, Inc. (CAI) has 36 SEC Form 4 filings (45 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Sep 23, 2026.
Inside the rolling window, 6 insiders at Caris Life Sciences, Inc. reported 4 open-market purchases totaling $1.6M and 5 open-market sales totaling $28.9M. The most active filer is President Spetzler David Baxley with 3 filings. Insiders have net sold $25.7M over the trailing 6 months. The most recent open-market filing is a sale of 7,500 shares by See Remarks Denton John Russel, dated Sep 22, 2026, worth $239K.
- Industry:Biotechnology
- CEO:David Dean Halbert
- Employees:1,846
- HQ:Irving, TX, US
- IPO:2025-06-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
Denton John RusselFirst in 11 months | See Remarks | Sale | 7,500 | $239K | Sep 23 | +14.2% | SEC ↗ |
Brille Brian JFirst filing | See Remarks | Sale | 400,000 | $12.1M | Sep 17 | +16.9% | SEC ↗ |
Spetzler David BaxleyFirst in 10 months | President | Sale | 478,000 | $11.9M | Sep 4 | +44.2% | SEC ↗ |
Spetzler David BaxleyFirst in 10 months | President | Sale | 119,212 | $3.0M | Sep 4 | +44.2% | SEC ↗ |
HALBERT JONFirst filing | Director | Purchase | 68,000 | $990K | Jul 13 | +111.8% | SEC ↗ |
Vacirca Jeff LFirst filing | Director | Purchase | 31,050 | $501K | May 12 | +115.6% | SEC ↗ |
Power Luke ThomasFirst filing | See Remarks | Sale | 62,250 | $1.7M | Dec 12 | +35.1% | SEC ↗ |
Denton John RusselFirst filing | See Remarks | Purchase | 4,184 | $101K | Nov 10 | +45.7% | SEC ↗ |
Spetzler David BaxleyFirst filing | President | Purchase | 400 | $10K | Nov 10 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does CAI have?
Caris Life Sciences, Inc. (CAI) has 36 SEC Form 4 filings (45 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Sep 23, 2026.
When was the most recent SEC Form 4 filing for CAI?
The most recent Form 4 filing for CAI on Tracefour is dated Sep 23, 2026.
Who is the most active insider at CAI?
The most active SEC Form 4 filer at CAI in the rolling window is President Spetzler David Baxley, with 3 filings.
What is the net insider flow at CAI over the last 6 months?
Over the trailing 180 days, insiders at CAI have net sold $25.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CAI in the current window?
Inside the rolling window, insiders at CAI bought $1.6M and sold $28.9M based on SEC Form 4 filings.
Can I get alerts for CAI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Caris Life Sciences, Inc. (CAI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Caris Life Sciences, Inc. is in the Healthcare sector.